198 related articles for article (PubMed ID: 11108892)
21. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery.
Chwalisz K
Hum Reprod; 1994 Jun; 9 Suppl 1():131-61. PubMed ID: 7962460
[TBL] [Abstract][Full Text] [Related]
22. Early pregnancy termination with mifepristone and misoprostol in the United States.
Spitz IM; Bardin CW; Benton L; Robbins A
N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
[TBL] [Abstract][Full Text] [Related]
23. Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone.
Fiscella J; Bonfiglio T; Winters P; Eisinger SH; Fiscella K
Hum Pathol; 2011 Jul; 42(7):947-53. PubMed ID: 21315422
[TBL] [Abstract][Full Text] [Related]
24. The immninent dawn of SPRMs in obstetrics and gynecology.
Chabbert-Buffet N; Pintiaux A; Bouchard P
Mol Cell Endocrinol; 2012 Jul; 358(2):232-43. PubMed ID: 22415029
[TBL] [Abstract][Full Text] [Related]
25. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
26. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.
Bouchard P; Chabbert-Buffet N; Fauser BC
Fertil Steril; 2011 Nov; 96(5):1175-89. PubMed ID: 21944187
[TBL] [Abstract][Full Text] [Related]
27. [Progesterone antagonists: biochemical and pharmacological aspects and clinical usefulness].
Terán Dávila J; Teppa Garrán A
Ginecol Obstet Mex; 2004 Feb; 72():76-84. PubMed ID: 15216905
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of progesterone receptor modulators and their effect on the endometrium.
Spitz IM
Curr Opin Obstet Gynecol; 2009 Aug; 21(4):318-24. PubMed ID: 19602929
[TBL] [Abstract][Full Text] [Related]
29. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterus.
Spitz IM; Robbins A
Hum Reprod Update; 1998; 4(5):584-93. PubMed ID: 10027612
[TBL] [Abstract][Full Text] [Related]
31. Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification system.
Afhüppe W; Sommer A; Müller J; Schwede W; Fuhrmann U; Möller C
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):105-15. PubMed ID: 19130882
[TBL] [Abstract][Full Text] [Related]
32. [Selective progesterone receptor modulators: future clinical applications].
Bouchard P; Ouzounian S; Chabbert-Buffet N
Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
Wardell SE; Edwards DP
Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
[TBL] [Abstract][Full Text] [Related]
34. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
[TBL] [Abstract][Full Text] [Related]
35. Nonsteroidal progesterone receptor modulators: structure activity relationships.
Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
[TBL] [Abstract][Full Text] [Related]
36. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
37. Modulation of oestrogenic effects by progesterone antagonists in the rat uterus.
Chwalisz K; Stöckemann K; Fritzemeier KH; Fuhrmann U
Hum Reprod Update; 1998; 4(5):570-83. PubMed ID: 10027611
[TBL] [Abstract][Full Text] [Related]
38. [Interest of selective progesterone receptor modulators in endometriosis].
Merviel P; Lourdel E; Sanguin S; Gagneur O; Cabry R; Nasreddine A
Gynecol Obstet Fertil; 2013 Sep; 41(9):524-8. PubMed ID: 23972920
[TBL] [Abstract][Full Text] [Related]
39. Mifepristone. Auxiliary therapeutic use in cancer and related disorders.
Koide SS
J Reprod Med; 1998 Jul; 43(7):551-60. PubMed ID: 9693404
[TBL] [Abstract][Full Text] [Related]
40. Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.
Elger W; Fähnrich M; Beier S; Qing SS; Chwalisz K
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1065-74. PubMed ID: 3479025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
